Alta Bioequities

Description

Alta Bioequities

Investor Profile

Alta Bioequities has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Post Ipo Equity (100%)

Country Focus

United States (100%)

Industry Focus

Biopharma
Biotechnology
Life Science
Oncology

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alta Bioequities frequently co-invest with?

Serrado Capital

North America, New York, United States, New York

Co-Investments: 1

Venrock Healthcare Capital Partners

North America, California, United States, Palo Alto

Co-Investments: 1

Avoro Ventures

North America, New York, United States, New York

Co-Investments: 1

Acuta Capital Partners

North America, California, United States, Belmont

Co-Investments: 1

RTW Investments

North America, New York, United States, New York

Co-Investments: 1

Biotechnology Value Fund

North America, California, United States, San Francisco

Co-Investments: 1

KVP Capital

Co-Investments: 1

Rock Springs Capital

North America, Maryland, United States, Baltimore

Co-Investments: 1

Avoro Capital Advisors

North America, New York, United States, New York

Co-Investments: 1

Acorn Bioventures

North America, New York, United States, New York

Co-Investments: 1

What are some of recent deals done by Alta Bioequities?

Aadi Bioscience

Pacific Palisades, California, United States

Aadi Bioscience develops a potentially mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.

BiopharmaBiotechnologyLife ScienceOncology

Post Ipo EquityAug 26, 2021

Amount Raised: $154,999,876

Alta Bioequities

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Alta Bioequities frequently co-invest with?

What are some of recent deals done by Alta Bioequities?

Ready to Raise Capital?

Pages

Free tools